Xenobiotic Particle Exposure and Microvascular Endpoints: A Call to Arms

Microcirculation

Volumn 19, Issue 2, 2012, Pages 126-142

  Stapleton, Phoebe A ^a   Minarchick, Valerie C ^a   Mccawley, Michael ^a   Knuckles, Travis L ^a   Nurkiewicz, Timothy R ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular; Exposure; Microcirculation; Nanoparticles; Particulate matter

Indexed keywords

METAL OXIDE; NANOPARTICLE; TITANIUM DIOXIDE; XENOBIOTIC AGENT;

AIR POLLUTANT; AIR POLLUTION; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HUMAN; INFLAMMATION; INHALATION; MATERIALS; MICROVASCULATURE; NANOTECHNOLOGY; NONHUMAN; OCCUPATIONAL EXPOSURE; PARTICLE SIZE; PARTICULATE MATTER; PRIORITY JOURNAL; REVIEW;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MICROCIRCULATION; PARTICULATE MATTER; XENOBIOTICS;

EID: 84856816700     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2011.00137.x     Document Type: Review

References (152)

1. Aitken RJ, Chaudhry MQ, Boxall AB, Hull M. Manufacture and use of nanomaterials: current status in the UK and global trends. Occup Med (Lond) 56: 300-306, 2006.
2. Apopa PL, Qian Y, Shao R, Guo N, Schwegler-Berry D, Pacurari M, Porter D, Shi X, Vallyathan V, Castranova V, Flynn DC. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part Fibre Toxicol 6: 1, 2009.
3. Bartoli CR, Wellenius GA, Diaz EA, Lawrence J, Coull BA, Akiyama I, Lee LM, Okabe K, Verrier RL, Godleski JJ. Mechanisms of inhaled fine particulate air pollution-induced arterial blood pressure changes. Environ Health Perspect 117: 361-366, 2009.
4. Behnke BJ, Prisby RD, Lesniewski LA, Donato AJ, Olin HM, Delp MD. Influence of ageing and physical activity on vascular morphology in rat skeletal muscle. J Physiol 575: 617-626, 2006.
5. Belfort MA, Saade GR, Snabes M, Dunn R, Moise KJ Jr, Cruz A, Young R. Hormonal status affects the reactivity of the cerebral vasculature. Am J Obstet Gynecol 172: 1273-1278, 1995.
6. Bell ML, Davis DL. Reassessment of the lethal London fog of 1952: novel indicators of acute and chronic consequences of acute exposure to air pollution. Environ Health Perspect 109(Suppl. 3): 389-394, 2001.
7. Borm PJ, Muller-Schulte D. Nanoparticles in drug delivery and environmental exposure: same size, same risks? Nanomedicine (Lond) 1: 235-249, 2006.
8. Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, Krutmann J, Warheit D, Oberdorster E. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 3: 11, 2006.
9. Bräuner EV, Møller P, Barregard L, Dragsted LO, Glasius M, Wåhlin P, Vinzents P, Raaschou-Nielsen O, Loft S. Exposure to ambient concentrations of particulate air pollution does not influence vascular function or inflammatory pathways in young healthy individuals. Part Fibre Toxicol 5: 13, 2008.
10. Brook RD. You are what you breathe: evidence linking air pollution and blood pressure. Curr Hypertens Rep 7: 427-434, 2005.
11. Brook RD. Cardiovascular effects of air pollution. Clin Sci (Lond) 115: 175-187, 2008.
12. Brook RD, Bard RL, Burnett RT, Shin HH, Vette A, Croghan C, Phillips M, Rodes C, Thornburg J, Williams R. Differences in blood pressure and vascular responses associated with ambient fine particulate matter exposures measured at the personal versus community level. Occup Environ Med 68: 224-230, 2011.
13. Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation 105: 1534-1536, 2002.
14. Brook RD, Rajagopalan S. Particulate matter air pollution and atherosclerosis. Curr Atheroscler Rep 12: 291-300, 2010.
15. Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr, Whitsel L, Kaufman JD. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 121: 2331-2378, 2010.
16. Brook RD, Urch B, Dvonch JT, Bard RL, Speck M, Keeler G, Morishita M, Marsik FJ, Kamal AS, Kaciroti N, Harkema J, Corey P, Silverman F, Gold DR, Wellenius G, Mittleman MA, Rajagopalan S, Brook JR. Insights into the mechanisms and mediators of the effects of air pollution exposure on blood pressure and vascular function in healthy humans. Hypertension 54: 659-667, 2009.
17. Bui T, Stevenson J, Hoekman J, Zhang S, Maravilla K, Ho RJ. Novel Gd nanoparticles enhance vascular contrast for high-resolution magnetic resonance imaging. PLoS One 5: e13082, 2010.
18. Cabrales P, Han G, Nacharaju P, Friedman AJ, Friedman JM. Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide. Am J Physiol Heart Circ Physiol 300: H49-H56, 2011.
19. Calderón-Garcidueñas L, Mora-Tiscareño A, Fordham LA, Chung CJ, García R, Osnaya N, Hernández J, Acuña H, Gambling TM, Villarreal-Calderón A, Carson J, Koren HS, Devlin RB. Canines as sentinel species for assessing chronic exposures to air pollutants: part 1. Respiratory pathology. Toxicol Sci 61: 342-355, 2001.
20. Calderón-Garcidueñas L, Gambling TM, Acuña H, García R, Osnaya N, Monroy S, Villarreal-Calderón A, Carson J, Koren HS, Devlin RB Systemic inflammation, endothelial dysfunction, and activation in clinically healthy children exposed to air pollutants. Inhal Toxicol 20: 499-506, 2008.
21. Campen MJ, Babu NS, Helms GA, Pett S, Wernly J, Mehran R, McDonald JD. Nonparticulate components of diesel exhaust promote constriction in coronary arteries from ApoE-/- mice. Toxicol Sci 88: 95-102, 2005.
22. Card JW, Jonaitis TS, Tafazoli S, Magnuson BA. An appraisal of the published literature on the safety and toxicity of food-related nanomaterials. Crit Rev Toxicol 41: 22-49, 2011.
23. Cherng TW, Campen MJ, Knuckles TL, Gonzalez BL, Kanagy NL. Impairment of coronary endothelial cell ET(B) receptor function after short-term inhalation exposure to whole diesel emissions. Am J Physiol Regul Integr Comp Physiol 297: R640-R647, 2009.
24. Cherng TW, Paffett ML, Jackson-Weaver O, Campen MJ, Walker BR, Kanagy NL. Mechanisms of diesel-induced endothelial nitric oxide synthase dysfunction in coronary arterioles. Environ Health Perspect 119: 98-103, 2011.
25. Cooper D, Stokes KY, Tailor A, Granger DN. Oxidative stress promotes blood cell-endothelial cell interactions in the microcirculation. Cardiovasc Toxicol 2: 165-180, 2002.
26. Costa DL, Dreher KL. Bioavailable transition metals in particulate matter mediate cardiopulmonary injury in healthy and compromised animal models. Environ Health Perspect 105(Suppl. 5): 1053-1060, 1997.
27. Deepak V, Umamaheshwaran PS, Guhan K, Nanthini RA, Krithiga B, Jaithoon NM, Gurunathan S. Synthesis of gold and silver nanoparticles using purified URAK. Colloids Surf B Biointerfaces 86: 353-358, 2011.
28. Delfino RJ, Staimer N, Tjoa T, Polidori A, Arhami M, Gillen DL, Kleinman MT, Vaziri ND, Longhurst J, Zaldivar F, Sioutas C. Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect 116: 898-906, 2008.
29. Dockery DW. Epidemiologic evidence of cardiovascular effects of particulate air pollution. Environ Health Perspect 109(Suppl. 4): 483-486, 2001.
30. Dockery DW, Pope CA III, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG Jr, Speizer FE. An association between air pollution and mortality in six U.S. cities. N Engl J Med 329: 1753-1759, 1993.
31. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJ. Nanotoxicology. Occup Environ Med 61: 727-728, 2004.
32. Doraiswamy A, Ovsianikov A, Gittard SD, Monteiro-Riviere NA, Crombez R, Montalvo E, Shen W, Chichkov BN, Narayan RJ. Fabrication of microneedles using two photon polymerization for transdermal delivery of nanomaterials. J Nanosci Nanotechnol 10: 6305-6312, 2010.
33. Dreher KL. Particulate matter physicochemistry and toxicology: In search of causality--a critical perspective. Inhal Toxicol 12(Suppl. 3): 45-57, 2000.
34. Van Eeden SF, Sin DD. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 75: 224-238, 2008.
35. Elder AC, Gelein R, Azadniv M, Frampton M, Finkelstein J, Oberdorster G. Systemic effects of inhaled ultrafine particles in two compromised, aged rat strains. Inhal Toxicol 16: 461-471, 2004.
36. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, Oberdörster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114: 1172-1178, 2006.
37. Evans SA, Al-Mosawi A, Adams RA, Berube KA. Inflammation, edema, and peripheral blood changes in lung-compromised rats after instillation with combustion-derived and manufactured nanoparticles. Exp Lung Res 32: 363-378, 2006.
38. Fang SC, Cavallari JM, Eisen EA, Chen JC, Mittleman MA, Christiani DC. Vascular function, inflammation, and variations in cardiac autonomic responses to particulate matter among welders. Am J Epidemiol 169: 848-856, 2009.
39. Fireman E. Induced sputum and occupational diseases other than asthma. Curr Opin Allergy Clin Immunol 9: 93-96, 2009.
40. Frampton MW. Does inhalation of ultrafine particles cause pulmonary vascular effects in humans? Inhal Toxicol 19(Suppl. 1): 75-79, 2007.
41. Gardner AW, Montgomery PS, Blevins SM, Parker DE. Gender and ethnic differences in arterial compliance in patients with intermittent claudication. J Vasc Surg 51: 610-615, 2010.
42. Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113: 1555-1560, 2005.
43. Ghelfi E, Rhoden CR, Wellenius GA, Lawrence J, Gonzalez-Flecha B. Cardiac oxidative stress and electrophysiological changes in rats exposed to concentrated ambient particles are mediated by TRP-dependent pulmonary reflexes. Toxicol Sci 102: 328-336, 2008.
44. Harder V, Gilmour P, Lentner B, Karg E, Takenaka S, Ziesenis A, Stampfl A, Kodavanti U, Heyder J, Schulz H. Cardiovascular responses in unrestrained WKY rats to inhaled ultrafine carbon particles. Inhal Toxicol 17: 29-42, 2005.
45. den Hartigh LJ, Lame MW, Ham W, Kleeman MJ, Tablin F, Wilson DW. Endotoxin and polycyclic aromatic hydrocarbons in ambient fine particulate matter from Fresno, California initiate human monocyte inflammatory responses mediated by reactive oxygen species. Toxicol In Vitro 24: 1993-2002, 2010.
46. He X, Nie H, Wang K, Tan W, Wu X, Zhang P. In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal Chem 80: 9597-9603, 2008.
47. Helfand WH, Lazarus J, Theerman P. Donora, Pennsylvania: an environmental disaster of the 20th century. Am J Public Health 91: 553, 2001.
48. Henderson RF, Driscoll KE, Harkema JR, Lindenschmidt RC, Chang IY, Maples KR, Barr EB. A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats. Fundam Appl Toxicol 24: 183-197, 1995.
49. Heyder J, Gebhart J, Rudolf G, schiller CF, Stahlhofen W. Deposition of particles in the human respiratory tract in the size range 0.005-15μm. J Aerosol Sci 17: 811-825, 1986.
50. Hillery AM, Jani PU, Florence AT. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60nm polystyrene particles. J Drug Target 2: 151-156, 1994.
51. Hood E. NIEHS strategic plan: new frontiers in environmental science and human health. Environ Health Perspect 114: A280-A283, 2006.
52. Huang A, Kaley G. Gender-specific regulation of cardiovascular function: estrogen as key player. Microcirculation 11: 9-38, 2004.
53. Inoue K, Takano H, Sakurai M, Oda T, Tamura H, Yanagisawa R, Shimada A, Yoshikawa T. Pulmonary exposure to diesel exhaust particles enhances coagulatory disturbance with endothelial damage and systemic inflammation related to lung inflammation. Exp Biol Med (Maywood) 231: 1626-1632, 2006.
54. Jani P, Halbert GW, Langridge J, Florence AT. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol 42: 821-826, 1990.
55. Kampfrath T, Maiseyeu A, Ying Z, Shah Z, Deiuliis JA, Xu X, Kherada N, Brook RD, Reddy KM, Padture NP, Parthasarathy S, Chen LC, Moffatt-Bruce S, Sun Q, Morawietz H, Rajagopalan S. Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circ Res 108: 716-726, 2011.
56. Kang LS, Chen B, Reyes RA, Leblanc AJ, Teng B, Mustafa SJ, Muller-Delp JM. Aging and estrogen alter endothelial reactivity to reactive oxygen species in coronary arterioles. Am J Physiol Heart Circ Physiol 300: H2105-H2115, 2011.
57. Khandoga A, Stampfl A, Takenaka S, Schulz H, Radykewicz R, Kreyling W, Krombach F. Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo. Circulation 109: 1320-1325, 2004.
58. Khandoga A, Stoeger T, Khandoga AG, Bihari P, Karg E, Ettehadieh D, Lakatos S, Fent J, Schulz H, Krombach F. Platelet adhesion and fibrinogen deposition in murine microvessels upon inhalation of nanosized carbon particles. J Thromb Haemost 8: 1632-1640, 2010.
59. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20: 575-583, 2008.
60. Kim JH, Kim MH, Jo DH, Yu YS, Lee TG, Kim JH. The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation. Biomaterials 32: 1865-1871, 2011.
61. Kim WY, Kim J, Park JD, Ryu HY, Yu IJ. Histological study of gender differences in accumulation of silver nanoparticles in kidneys of Fischer 344 rats. J Toxicol Environ Health A 72: 1279-1284, 2009.
62. Kirkpatrick CJ, Fuchs S, Unger RE. Co-culture systems for vascularization - l earning from nature. Adv Drug Deliv Rev 63: 291-299, 2011.
63. Knuckles TL, Lund AK, Lucas SN, Campen MJ. Diesel exhaust exposure enhances venoconstriction via uncoupling of eNOS. Toxicol Appl Pharmacol 230: 346-351, 2008.
64. Knuckles TL, Yi J, Frazer DG, Leonard HD, Chen BT, Castranova V, Nurkiewicz TR. Nanoparticle inhalation alters systemic arteriolar vasoreactivity through sympathetic and cyclooxygenase-mediated pathways. Nanotoxicology, DOI:
65. Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdörster G, Ziesenis A. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 65: 1513-1530, 2002.
66. Kreyling WG, Semmler-Behnke M, Moller W. Ultrafine particle-lung interactions: does size matter? J Aerosol Med 19: 74-83, 2006.
67. Kreyling WG, Semmler-Behnke M, Seitz J, Scymczak W, Wenk A, Mayer P, Takenaka S, Oberdörster G. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol 21(Suppl. 1): 55-60, 2009.
68. LeBlanc AJ, Cumpston JL, Chen BT, Frazer D, Castranova V, Nurkiewicz TR. Nanoparticle inhalation impairs endothelium-dependent vasodilation in subepicardial arterioles. J Toxicol Environ Health A 72: 1576-1584, 2009.
69. LeBlanc AJ, Moseley AM, Chen BT, Frazer D, Castranova V, Nurkiewicz TR. Nanoparticle inhalation impairs coronary microvascular reactivity via a local reactive oxygen species-dependent mechanism. Cardiovasc Toxicol 10: 27-36, 2010.
70. LeBlanc AJ, Reyes R, Kang LS, Dailey RA, Stallone JN, Moningka NC, Muller-Delp JM. Estrogen replacement restores flow-induced vasodilation in coronary arterioles of aged and ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 297: R1713-R1723, 2009.
71. Legramante JM, Valentini F, Magrini A, Palleschi G, Sacco S, Iavicoli I, Pallante M, Moscone D, Galante A, Bergamaschi E, Bergamaschi A, Pietroiusti A. Cardiac autonomic regulation after lung exposure to carbon nanotubes. Hum Exp Toxicol 28: 369-375, 2009.
72. Levin ML, Goldstein H, Gerhardt PR. Cancer and tobacco smoking; a preliminary report. J Am Med Assoc 143: 336-338, 1950.
73. Linderman JR, Boegehold MA. Modulation of arteriolar sympathetic constriction by local nitric oxide: onset during rapid juvenile growth. Microvasc Res 56: 192-202, 1998.
74. Lippmann M, Frampton M, Schwartz J, Dockery D, Schlesinger R, Koutrakis P, Froines J, Nel A, Finkelstein J, Godleski J, Kaufman J, Koenig J, Larson T, Luchtel D, Liu LJ, Oberdorster G, Peters A, Sarnat J, Sioutas C, Suh H, Sullivan J, Utell M, Wichmann E, Zelikoff J. The U.S. Environmental Protection Agency Particulate Matter Health Effects Research Centers Program: a midcourse report of status, progress, and plans. Environ Health Perspect 111: 1074-1092, 2003.
75. Liu L, Ruddy T, Dalipaj M, Poon R, Szyszkowicz M, You H, Dales RE, Wheeler AJ. Effects of indoor, outdoor, and personal exposure to particulate air pollution on cardiovascular physiology and systemic mediators in seniors. J Occup Environ Med 51: 1088-1098, 2009.
76. Lövestam G., Rauscher H., Roebben G., Klüttgen B. S., Gibson N., Putaud J. P., Stamm H. Considerations on a definition of nanomaterial for regulatory purposes, JRC Reference Report. EUR 24403 EN, 2010.
77. Magari SR, Hauser R, Schwartz J, Williams PL, Smith TJ, Christiani DC. Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation 104: 986-991, 2001.
78. Mahajan SD, Roy I, Xu G, Yong KT, Ding H, Aalinkeel R, Reynolds J, Sykes D, Nair BB, Lin EY, Prasad PN, Schwartz SA. Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles. Curr HIV Res 8: 396-404, 2010.
79. Maier KL, Alessandrini F, Beck-Speier I, Hofer TP, Diabaté S, Bitterle E, Stöger T, Jakob T, Behrendt H, Horsch M, Beckers J, Ziesenis A, Hültner L, Frankenberger M, Krauss-Etschmann S, Schulz H. Health effects of ambient particulate matter - biological mechanisms and inflammatory responses to in vitro and in vivo particle exposures. Inhal Toxicol 20: 319-337, 2008.
80. Maynard AD, Warheit DB, Philbert MA. The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol Sci 120(Suppl. 1): S109-S129, 2011.
81. Menache MG, Raabe OG, Miller FJ. An empirical dosimetry model of aerodynamic particle deposition in the rat respiratory tract. Inhal Toxicol 8: 539-578, 1995.
82. Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Schwegler-Berry D, Castranova V, Porter DW. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre Toxicol 7: 28, 2010.
83. Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Friend S, Castranova V, Porter DW. Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre Toxicol 8: 21, 2011.
84. Mills NL, Törnqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon NA, Donaldson K, Blomberg A, Sandstrom T, Newby DE. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation 112: 3930-3936, 2005.
85. MINChar Initiative. Recommended minimum physical and chemical parameters for characterizing nanomaterials on toxicology studies. Internet, 2008. 16 June, 2011
86. Mondalek FG, Ashley RA, Roth CC, Kibar Y, Shakir N, Ihnat MA, Fung KM, Grady BP, Kropp BP, Lin HK. Enhanced angiogenesis of modified porcine small intestinal submucosa with hyaluronic acid-poly(lactide-co-glycolide) nanoparticles: from fabrication to preclinical validation. J Biomed Mater Res A 94: 712-719, 2010.
87. Monteiro-Riviere NA, Wiench K, Landsiedel R, Schulte S, Inman AO, Riviere JE. Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study. Toxicol Sci 123: 264-80, 2011.
88. Mortensen LJ, Oberdorster G, Pentland AP, Delouise LA. In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett 8: 2779-2787, 2008.
89. Muhlfeld C, Gehr P, Rothen-Rutishauser B. Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. Swiss Med Wkly 138: 387-391, 2008.
90. Muller RH, Shegokar R, Keck CM. 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Curr Drug Discov Technol 8: 207-27, 2011.
91. Nemery B, Hoet PH, Nemmar A. The Meuse Valley fog of 1930: an air pollution disaster. Lancet 357: 704-708, 2001.
92. Nemmar A, Al-Salam S, Dhanasekaran S, Sudhadevi M, Ali BH. Pulmonary exposure to diesel exhaust particles promotes cerebral microvessel thrombosis: protective effect of a cysteine prodrug l-2-oxothiazolidine-4-carboxylic acid. Toxicology 263: 84-92, 2009.
93. Nemmar A, Hoet PH, Nemery B. Translocation of ultrafine particles. Environ Health Perspect 114: A211-A212, 2006.
94. Nemmar A, Hoylaerts MF, Hoet PH, Vermylen J, Nemery B. Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol 186: 38-45, 2003.
95. Nieman GF, Clark WR Jr, Goyette D, Hart AK, Bredenberg CE. Wood smoke inhalation increases pulmonary microvascular permeability. Surgery 105: 481-487, 1989.
96. Niwa Y, Iwai N. Nanomaterials induce oxidized low-density lipoprotein cellular uptake in macrophages and platelet aggregation. Circ J 71: 437-444, 2007.
97. Nurkiewicz TR, Porter DW, Barger M, Castranova V, Boegehold MA. Particulate matter exposure impairs systemic microvascular endothelium-dependent dilation. Environ Health Perspect 112: 1299-1306, 2004.
98. Nurkiewicz TR, Porter DW, Barger M, Millecchia L, Rao KM, Marvar PJ, Hubbs AF, Castranova V, Boegehold MA. Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environ Health Perspect 114: 412-419, 2006.
99. Nurkiewicz TR, Porter DW, Hubbs AF, Cumpston JL, Chen BT, Frazer DG, Castranova V. Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction. Part Fibre Toxicol 5: 1, 2008.
100. Nurkiewicz TR, Porter DW, Hubbs AF, Stone S, Chen BT, Frazer DG, Boegehold MA, Castranova V. Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling. Toxicol Sci 110: 191-203, 2009.
101. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 65: 1531-1543, 2002.
102. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16: 437-445, 2004.
103. Oberdorster G, Utell MJ. Ultrafine particles in the urban air: to the respiratory tract - and beyond? Environ Health Perspect 110: A440-A441, 2002.
104. Pacurari M, Castranova V, Vallyathan V. Single- and multi-wall carbon nanotubes versus asbestos: are the carbon nanotubes a new health risk to humans? J Toxicol Environ Health A 73: 378-395, 2010.
105. Pery AR, Brochot C, Hoet PH, Nemmar A, Bois FY. Development of a physiologically based kinetic model for 99m-technetium-labelled carbon nanoparticles inhaled by humans. Inhal Toxicol 21: 1099-1107, 2009.
106. Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 103: 2810-2815, 2001.
107. Peters A, Liu E, Verrier RL, Schwartz J, Gold DR, Mittleman M, Baliff J, Oh JA, Allen G, Monahan K, Dockery DW. Air pollution and incidence of cardiac arrhythmia. Epidemiology 11: 11-17, 2000.
108. Pham H, Bonham AC, Pinkerton KE, Chen CY. Central neuroplasticity and decreased heart rate variability after particulate matter exposure in mice. Environ Health Perspect 117: 1448-1453, 2009.
109. Pierce JP, Messer K, White MM, Cowling DW, Thomas DP. Prevalence of heavy smoking in California and the United States, 1965-2007. JAMA 305:1106-1112, 2011.
110. Poole D, Behnke B, Musch T. Capillary hemodynamics and oxygen pressures in the aging microcirculation. Microcirculation 13: 289-299, 2006.
111. Pope CA III. Epidemiology of fine particulate air pollution and human health: biologic mechanisms and who's at risk? Environ Health Perspect 108(Suppl. 4): 713-723, 2000.
112. Pope CA III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 287: 1132-1141, 2002.
113. Pope CA III, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 109: 71-77, 2004.
114. Prisby RD, Muller-Delp J, Delp MD, Nurkiewicz TR. Age, gender, and hormonal status modulate the vascular toxicity of the diesel exhaust extract phenanthraquinone. J Toxicol Environ Health A 71: 464-470, 2008.
115. Qu S, Liberda EN, Qu Q, Chen LC. In vitro assessment of the inflammatory response of respiratory endothelial cells exposed to particulate matter. J Toxicol Environ Health A 73: 1113-1121, 2010.
116. Rao CN, Govindaraj A. Carbon nanotubes from organometallic precursors. Acc Chem Res 35: 998-1007, 2002.
117. Reddy AR, Krishna DR, Reddy YN, Himabindu V. Translocation and extra pulmonary toxicities of multi wall carbon nanotubes in rats. Toxicol Mech Methods 20: 267-272, 2010.
118. Rhoden CR, Wellenius GA, Ghelfi E, Lawrence J, Gonzalez-Flecha B. PM-induced cardiac oxidative stress and dysfunction are mediated by autonomic stimulation. Biochim Biophys Acta 1725: 305-313, 2005.
119. Routledge HC, Manney S, Harrison RM, Ayres JG, Townend JN. Effect of inhaled sulphur dioxide and carbon particles on heart rate variability and markers of inflammation and coagulation in human subjects. Heart 92: 220-227, 2006.
120. Rundell KW, Caviston R. Ultrafine and fine particulate matter inhalation decreases exercise performance in healthy subjects. J Strength Cond Res 22: 2-5, 2008.
121. Rundell KW, Hoffman JR, Caviston R, Bulbulian R, Hollenbach AM. Inhalation of ultrafine and fine particulate matter disrupts systemic vascular function. Inhal Toxicol 19: 133-140, 2007.
122. Sager TM, Kommineni C, Castranova V. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area. Part Fibre Toxicol 5: 17, 2008.
123. Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL. Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. N Engl J Med 343: 1742-1749, 2000.
124. Samora JB, Frisbee JC, Boegehold MA. Hydrogen peroxide emerges as a regulator of tone in skeletal muscle arterioles during juvenile growth. Microcirculation 15: 151-161, 2008.
125. Samora JB, Frisbee JC, Boegehold MA. Increased myogenic responsiveness of skeletal muscle arterioles with juvenile growth. Am J Physiol Heart Circ Physiol 294: H2344-H2351, 2008.
126. Segal SS. Regulation of blood flow in the microcirculation. Microcirculation 12: 33-45, 2005.
127. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling WG. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 16: 453-459, 2004.
128. Shah AP, Pietropaoli AP, Frasier LM, Speers DM, Chalupa DC, Delehanty JM, Huang LS, Utell MJ, Frampton MW. Effect of inhaled carbon ultrafine particles on reactive hyperemia in healthy human subjects. Environ Health Perspect 116: 375-380, 2008.
129. Shieh KJ, Li M, Lee YH, Sheu SD, Liu YT, Wang YC. Antibacterial performance of photocatalyst thin film fabricated by defection effect in visible light. Nanomedicine 2: 121-126, 2006.
130. Singer G, Granger DN. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance. Microcirculation 14: 375-387, 2007.
131. Smith RA. Air and Rain. The Beginning of a Chemical Climatology. London: Longmans, Green, and co, 1872.
132. Srinivas PR, Philbert M, Vu TQ, Huang Q, Kokini JL, Saltos E, Chen H, Peterson CM, Friedl KE, McDade-Ngutter C, Hubbard V, Starke-Reed P, Miller N, Betz JM, Dwyer J, Milner J, Ross SA. Nanotechnology research: applications in nutritional sciences. J Nutr 140: 119-124, 2010.
133. Stahlhofen W, Rudolf G, James A. Intercomparison of experimental regional aerosol deposition data. J Aerosol Med 2: 285-308, 1989.
134. Stewart JC, Chalupa DC, Devlin RB, Frasier LM, Huang LS, Little EL, Lee SM, Phipps RP, Pietropaoli AP, Taubman MB, Utell MJ, Frampton MW. Vascular effects of ultrafine particles in persons with type 2 diabetes. Environ Health Perspect 118: 1692-1698, 2010.
135. Stone V, Johnston H, Clift MJ. Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions. IEEE Trans Nanobioscience 6: 331-340, 2007.
136. Sun D, Meng TT, Loong TH, Hwa TJ. Removal of natural organic matter from water using a nano-structured photocatalyst coupled with filtration membrane. Water Sci Technol 49: 103-110, 2004.
137. Tankersley CG, Bierman A, Rabold R. Variation in heart rate regulation and the effects of particle exposure in inbred mice. Inhal Toxicol 19: 621-629, 2007.
138. Tiwari R, Pathak K. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm 415: 232-43, 2011.
139. Totlandsdal AI, Refsnes M, Skomedal T, Osnes JB, Schwarze PE, Lag M. Particle-induced cytokine responses in cardiac cell cultures--the effect of particles versus soluble mediators released by particle-exposed lung cells. Toxicol Sci 106: 233-241, 2008.
140. Totlandsdal AI, Skomedal T, Lag M, Osnes JB, Refsnes M. Pro-inflammatory potential of ultrafine particles in mono- and co-cultures of primary cardiac cells. Toxicology 247: 23-32, 2008.
141. Ulrich MM, Alink GM, Kumarathasan P, Vincent R, Boere AJ, Cassee FR. Health effects and time course of particulate matter on the cardiopulmonary system in rats with lung inflammation. J Toxicol Environ Health A 65: 1571-1595, 2002.
142. Urch B, Silverman F, Corey P, Brook JR, Lukic KZ, Rajagopalan S, Brook RD. Acute blood pressure responses in healthy adults during controlled air pollution exposures. Environ Health Perspect 113: 1052-1055, 2005.
143. US Dept of Health and Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. 89-8411, 1-713. 1989. Center for Chronic Disease Prevention and Health Promotion. Office on Smoking and Health, Bethesda, MD.
144. Vanwinkle BA, de Mesy Bentley KL, Malecki JM, Gunter KK, Evans IM, Elder A, Finkelstein JN, Oberdörster G, Gunter TE. Nanoparticle (NP) uptake by type I alveolar epithelial cells and their oxidant stress response. Nanotoxicology 3: 307-318, 2009.
145. Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 89: 1269-1339, 2009.
146. Wallace L, Ott W. Personal exposure to ultrafine particles. J Expo Sci Environ Epidemiol 21: 20-30, 2011.
147. Wallenborn JG, McGee JK, Schladweiler MC, Ledbetter AD, Kodavanti UP. Systemic translocation of particulate matter-associated metals following a single intratracheal instillation in rats. Toxicol Sci 98: 231-239, 2007.
148. Wingard CJ, Walters DM, Cathey BL, Hilderbrand SC, Katwa P, Lin S, Ke PC, Podila R, Rao A, Lust RM, Brown JM. Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. Nanotoxicology, DOI:
149. Wong BA. Inhalation exposure systems: design, methods and operation. Toxicol Pathol 35: 3-14, 2007.
150. Yamawaki H, Iwai N. Mechanisms underlying nano-sized air-pollution-mediated progression of atherosclerosis: carbon black causes cytotoxic injury/inflammation and inhibits cell growth in vascular endothelial cells. Circ J 70: 129-140, 2006.
151. Zanobetti A, Canner MJ, Stone PH, Schwartz J, Sher D, Eagan-Bengston E, Gates KA, Hartley LH, Suh H, Gold DR. Ambient pollution and blood pressure in cardiac rehabilitation patients. Circulation 110: 2184-2189, 2004.
152. Zhu MT, Wang B, Wang Y, Yuan L, Wang HJ, Wang M, Ouyang H, Chai ZF, Feng WY, Zhao YL. Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: risk factors for early atherosclerosis. Toxicol Lett 203: 162-171, 2011.